Division of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Acta Obstet Gynecol Scand. 2018 Apr;97(4):491-499. doi: 10.1111/aogs.13264. Epub 2017 Dec 15.
Clinical decision-making in perinatology involves trade-offs between two intricately related individuals - mother and fetus. Decision-making in perinatology is challenging due to competing interests of the mother and the fetus. Although decision analytic methods are increasingly used to develop processes for clinical and cost-effectiveness analyses in perinatology, there are no guidelines on the conduct and reporting of decision analysis studies that takes into account the complexities of the mother-fetus dyad. This article describes the basics of decision analysis and highlights areas that require special consideration in the perinatal context. It emphasizes the importance of obtaining patient preferences related to combined maternal-fetal health states, stresses the relevance of both maternal and offspring health outcomes over appropriate time horizons, and explains challenges around the use of quality-adjusted life years as an outcome measure in perinatology. It also provides insight into the complexities of dyad status in clinical and cost-effectiveness analyses in perinatology.
围产医学中的临床决策涉及到母亲和胎儿这两个紧密相关的个体之间的权衡。围产医学中的决策制定具有挑战性,因为母亲和胎儿的利益相互竞争。尽管决策分析方法越来越多地被用于制定围产医学中的临床和成本效益分析的流程,但没有关于考虑母婴二元体复杂性的决策分析研究的进行和报告的指南。本文描述了决策分析的基础知识,并强调了在围产期背景下需要特别考虑的领域。它强调了获得与母婴健康状况相关的患者偏好的重要性,强调了在适当的时间范围内关注母婴健康结果的相关性,并解释了在围产医学中使用质量调整生命年来作为结果衡量的挑战。它还深入了解了围产医学中临床和成本效益分析中二元体状态的复杂性。